Trade Annexon, Inc. - ANNX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.025457% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003235% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Annexon Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 2.78 |
Open* | 2.84 |
1-Year Change* | -12.62% |
Day's Range* | 2.49 - 2.84 |
52 wk Range | 2.07-7.65 |
Average Volume (10 days) | 2.25M |
Average Volume (3 months) | 15.94M |
Market Cap | 151.29M |
P/E Ratio | -100.00K |
Shares Outstanding | 53.08M |
Revenue | N/A |
EPS | -2.47 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Aug 7, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 2.78 | 0.71 | 34.30% | 2.07 | 2.81 | 2.05 |
May 25, 2023 | 2.06 | -0.36 | -14.88% | 2.42 | 2.44 | 2.04 |
May 24, 2023 | 5.15 | -0.33 | -6.02% | 5.48 | 5.63 | 5.05 |
May 23, 2023 | 5.57 | -0.22 | -3.80% | 5.79 | 6.09 | 5.56 |
May 22, 2023 | 5.94 | 0.27 | 4.76% | 5.67 | 6.04 | 5.66 |
May 19, 2023 | 5.86 | 0.13 | 2.27% | 5.73 | 5.97 | 5.67 |
May 18, 2023 | 5.76 | -0.47 | -7.54% | 6.23 | 6.61 | 5.72 |
May 17, 2023 | 6.35 | 0.38 | 6.37% | 5.97 | 6.40 | 5.78 |
May 16, 2023 | 6.00 | 0.06 | 1.01% | 5.94 | 6.15 | 5.77 |
May 15, 2023 | 6.03 | 0.60 | 11.05% | 5.43 | 6.22 | 5.41 |
May 12, 2023 | 5.44 | -0.02 | -0.37% | 5.46 | 5.59 | 5.41 |
May 11, 2023 | 5.45 | -0.15 | -2.68% | 5.60 | 5.67 | 5.38 |
May 10, 2023 | 5.59 | 0.20 | 3.71% | 5.39 | 5.79 | 5.35 |
May 9, 2023 | 5.43 | 0.33 | 6.47% | 5.10 | 5.48 | 4.90 |
May 8, 2023 | 5.21 | 0.17 | 3.37% | 5.04 | 5.26 | 5.03 |
May 5, 2023 | 5.24 | 0.14 | 2.75% | 5.10 | 5.38 | 5.07 |
May 4, 2023 | 5.17 | 0.23 | 4.66% | 4.94 | 5.19 | 4.90 |
May 3, 2023 | 5.06 | 0.36 | 7.66% | 4.70 | 5.15 | 4.66 |
May 2, 2023 | 4.85 | -0.55 | -10.19% | 5.40 | 5.40 | 4.85 |
May 1, 2023 | 5.43 | 0.18 | 3.43% | 5.25 | 5.48 | 5.25 |
Annexon, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, June 8, 2023 | ||
Time (UTC) 13:30 | Country US
| Event Annexon Inc Annual Shareholders Meeting Annexon Inc Annual Shareholders MeetingForecast -Previous - |
Friday, June 9, 2023 | ||
Time (UTC) 16:00 | Country US
| Event Annexon Inc Annual Shareholders Meeting Annexon Inc Annual Shareholders MeetingForecast -Previous - |
Monday, August 7, 2023 | ||
Time (UTC) 10:59 | Country US
| Event Q2 2023 Annexon Inc Earnings Release Q2 2023 Annexon Inc Earnings ReleaseForecast -Previous - |
Wednesday, November 1, 2023 | ||
Time (UTC) 12:30 | Country US
| Event Q3 2023 Annexon Inc Earnings Release Q3 2023 Annexon Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 |
Total Operating Expense | 145.599 | 130.713 | 63.469 | 32.328 | 19.112 |
Selling/General/Admin. Expenses, Total | 33.098 | 30.647 | 14.198 | 7.994 | 3.619 |
Research & Development | 112.501 | 100.066 | 49.271 | 24.524 | 15.528 |
Operating Income | -145.599 | -130.713 | -63.469 | -32.328 | -19.112 |
Other, Net | 3.652 | 0.385 | 0.048 | -4.865 | 0.769 |
Net Income Before Taxes | -141.947 | -130.323 | -63.412 | -37.179 | -18.303 |
Net Income After Taxes | -141.947 | -130.323 | -63.412 | -37.183 | -18.304 |
Net Income Before Extra. Items | -141.947 | -130.323 | -63.412 | -37.183 | -18.304 |
Total Extraordinary Items | |||||
Net Income | -141.947 | -130.323 | -63.412 | -37.183 | -18.304 |
Total Adjustments to Net Income | 0 | -6.924 | -1.095 | -0.176 | |
Income Available to Common Excl. Extra. Items | -141.947 | -130.323 | -70.336 | -38.278 | -18.48 |
Income Available to Common Incl. Extra. Items | -141.947 | -130.323 | -70.336 | -38.278 | -18.48 |
Diluted Net Income | -141.947 | -130.323 | -70.336 | -38.278 | -18.48 |
Diluted Weighted Average Shares | 54.6736 | 38.3163 | 16.9624 | 187.289 | 187.289 |
Diluted EPS Excluding Extraordinary Items | -2.59626 | -3.40124 | -4.14658 | -0.20438 | -0.09867 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
Diluted Normalized EPS | -2.59626 | -3.40124 | -4.14658 | -0.20504 | -0.09879 |
Unusual Expense (Income) | -0.19 | -0.035 | |||
Interest Income (Expense), Net Non-Operating | 0.005 | 0.009 | 0.014 | 0.04 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 |
Total Operating Expense | 41.242 | 36.695 | 36.069 | 37.409 | 35.426 |
Selling/General/Admin. Expenses, Total | 8.897 | 8.16 | 8.207 | 8.303 | 8.428 |
Research & Development | 32.345 | 28.535 | 27.862 | 29.106 | 26.998 |
Operating Income | -41.242 | -36.695 | -36.069 | -37.409 | -35.426 |
Other, Net | 2.566 | 2.312 | 1.015 | 0.272 | 0.053 |
Net Income Before Taxes | -38.676 | -34.383 | -35.054 | -37.137 | -35.373 |
Net Income After Taxes | -38.676 | -34.383 | -35.054 | -37.137 | -35.373 |
Net Income Before Extra. Items | -38.676 | -34.383 | -35.054 | -37.137 | -35.373 |
Net Income | -38.676 | -34.383 | -35.054 | -37.137 | -35.373 |
Total Adjustments to Net Income | |||||
Income Available to Common Excl. Extra. Items | -38.676 | -34.383 | -35.054 | -37.137 | -35.373 |
Income Available to Common Incl. Extra. Items | -38.676 | -34.383 | -35.054 | -37.137 | -35.373 |
Diluted Net Income | -38.676 | -34.383 | -35.054 | -37.137 | -35.373 |
Diluted Weighted Average Shares | 73.8556 | 72.563 | 68.6529 | 38.5844 | 38.5634 |
Diluted EPS Excluding Extraordinary Items | -0.52367 | -0.47384 | -0.5106 | -0.96249 | -0.91727 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.52367 | -0.47384 | -0.5106 | -0.96249 | -0.91727 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 248.098 | 247.693 | 354.011 | 45.406 | 45.706 |
Cash and Short Term Investments | 242.657 | 242.715 | 351.206 | 43.931 | 44.175 |
Cash & Equivalents | 140.02 | 74.843 | 268.565 | 43.931 | 44.175 |
Prepaid Expenses | 5.238 | 4.515 | 2.802 | 1.396 | 1.306 |
Total Assets | 285.096 | 287.04 | 355.946 | 49.898 | 48.149 |
Property/Plant/Equipment, Total - Net | 35.966 | 38.181 | 1.935 | 2.138 | 2.345 |
Property/Plant/Equipment, Total - Gross | 38.849 | 38.97 | 3.906 | 3.442 | 3.156 |
Accumulated Depreciation, Total | -2.883 | -0.789 | -1.971 | -1.304 | -0.811 |
Other Long Term Assets, Total | 1.032 | 1.166 | 0 | 2.354 | 0.098 |
Total Current Liabilities | 22.36 | 21.744 | 10.622 | 4.931 | 3.326 |
Accounts Payable | 7.416 | 11.153 | 3.734 | 2.371 | 1.271 |
Accrued Expenses | 14.764 | 10.452 | 6.497 | 2.194 | 1.713 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.18 | 0.139 | 0.391 | 0.366 | 0.342 |
Total Liabilities | 53.902 | 55.131 | 11.668 | 6.368 | 5.129 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 31.542 | 33.387 | 1.046 | 1.437 | 1.803 |
Total Equity | 231.194 | 231.909 | 344.278 | 43.53 | 43.02 |
Redeemable Preferred Stock | 0 | 0 | 143.984 | 107.222 | |
Common Stock | 0.048 | 0.039 | 0.038 | 0.004 | 0.004 |
Additional Paid-In Capital | 669.78 | 528.365 | 510.309 | 2.202 | 1.257 |
Retained Earnings (Accumulated Deficit) | -438.262 | -296.315 | -165.992 | -102.58 | -65.397 |
Other Equity, Total | -0.372 | -0.18 | -0.077 | -0.08 | -0.066 |
Total Liabilities & Shareholders’ Equity | 285.096 | 287.04 | 355.946 | 49.898 | 48.149 |
Total Common Shares Outstanding | 47.723 | 38.5608 | 38.1576 | 187.289 | 187.289 |
Total Receivables, Net | 0 | 0.003 | 0.079 | 0.225 | |
Short Term Investments | 102.637 | 167.872 | 82.641 | ||
Other Current Assets, Total | 0.203 | 0.463 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 232.536 | 248.098 | 274.777 | 181.372 | 211.254 |
Cash and Short Term Investments | 228.165 | 242.657 | 269.519 | 177.594 | 206.659 |
Cash & Equivalents | 144.12 | 140.02 | 210.658 | 104.614 | 112.828 |
Short Term Investments | 84.045 | 102.637 | 58.861 | 72.98 | 93.831 |
Total Receivables, Net | |||||
Prepaid Expenses | 4.206 | 5.238 | 5.201 | 3.741 | 4.461 |
Total Assets | 268.778 | 285.096 | 312.722 | 220.704 | 250.569 |
Property/Plant/Equipment, Total - Net | 35.198 | 35.966 | 36.709 | 37.282 | 37.908 |
Accumulated Depreciation, Total | -3.419 | -2.883 | -2.353 | -1.834 | -1.295 |
Other Long Term Assets, Total | 1.044 | 1.032 | 1.236 | 2.05 | 1.407 |
Total Current Liabilities | 22.941 | 22.36 | 20.22 | 20.254 | 17.053 |
Accounts Payable | 10.346 | 7.416 | 6.921 | 10.301 | 9.378 |
Accrued Expenses | 12.211 | 14.764 | 13.129 | 9.789 | 7.486 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.384 | 0.18 | 0.17 | 0.164 | 0.189 |
Total Liabilities | 53.917 | 53.902 | 52.12 | 52.66 | 49.955 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 30.976 | 31.542 | 31.9 | 32.406 | 32.902 |
Total Equity | 214.861 | 231.194 | 260.602 | 168.044 | 200.614 |
Common Stock | 0.053 | 0.048 | 0.048 | 0.039 | 0.039 |
Additional Paid-In Capital | 691.963 | 669.78 | 664.839 | 537.269 | 532.636 |
Retained Earnings (Accumulated Deficit) | -476.938 | -438.262 | -403.879 | -368.825 | -331.688 |
Other Equity, Total | -0.217 | -0.372 | -0.406 | -0.439 | -0.373 |
Total Liabilities & Shareholders’ Equity | 268.778 | 285.096 | 312.722 | 220.704 | 250.569 |
Total Common Shares Outstanding | 53.0807 | 47.723 | 47.6265 | 38.6039 | 38.5636 |
Property/Plant/Equipment, Total - Gross | 38.617 | 38.849 | 39.062 | 39.116 | 39.203 |
Other Current Assets, Total | 0.165 | 0.203 | 0.057 | 0.037 | 0.134 |
Redeemable Preferred Stock |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -141.947 | -130.323 | -63.412 | -37.183 | -18.304 |
Cash From Operating Activities | -116.309 | -106.11 | -53.087 | -28.358 | -17.19 |
Cash From Operating Activities | 2.106 | 2.141 | 0.667 | 0.493 | 0.488 |
Non-Cash Items | 19.794 | 18.788 | 4.941 | 7.707 | 0.148 |
Cash Taxes Paid | 0 | 0.002 | 0.001 | ||
Changes in Working Capital | 3.738 | 3.284 | 4.717 | 0.625 | 0.478 |
Cash From Investing Activities | 58.443 | -88.236 | -83.164 | -0.267 | -0.017 |
Capital Expenditures | -6.526 | -1.654 | -0.464 | -0.267 | -0.017 |
Cash From Financing Activities | 122.908 | 1.795 | 360.876 | 28.395 | 58.456 |
Issuance (Retirement) of Stock, Net | 130.896 | 1.795 | 363.85 | 30 | 58.456 |
Foreign Exchange Effects | 0.001 | -0.005 | 0.009 | -0.014 | -0.04 |
Net Change in Cash | 65.043 | -192.556 | 224.634 | -0.244 | 41.209 |
Financing Cash Flow Items | -7.988 | 0 | -2.974 | -1.605 | 0 |
Other Investing Cash Flow Items, Total | 64.969 | -86.582 | -82.7 | ||
Issuance (Retirement) of Debt, Net | 0 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -38.676 | -141.947 | -107.564 | -72.51 | -35.373 |
Cash From Operating Activities | -32.993 | -116.309 | -89.17 | -58.452 | -30.288 |
Cash From Operating Activities | 0.536 | 2.106 | 1.576 | 1.058 | 0.518 |
Non-Cash Items | 3.969 | 19.794 | 14.89 | 9.842 | 4.862 |
Changes in Working Capital | 1.178 | 3.738 | 1.928 | 3.158 | -0.295 |
Cash From Investing Activities | 19.517 | 58.443 | 102.058 | 87.96 | 68.251 |
Capital Expenditures | -0.137 | -6.526 | -6.244 | -6.075 | -5.214 |
Other Investing Cash Flow Items, Total | 19.654 | 64.969 | 108.302 | 94.035 | 73.465 |
Cash From Financing Activities | 17.581 | 122.908 | 122.8 | 0.132 | 0.019 |
Financing Cash Flow Items | -7.988 | -7.853 | |||
Issuance (Retirement) of Stock, Net | 17.581 | 130.896 | 130.653 | 0.132 | 0.019 |
Foreign Exchange Effects | -0.005 | 0.001 | -0.007 | -0.003 | 0.003 |
Net Change in Cash | 4.1 | 65.043 | 135.681 | 29.637 | 37.985 |
Issuance (Retirement) of Debt, Net |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Satter Management Co., L.P. | Private Equity | 13.2922 | 7056024 | 0 | 2023-03-31 | MED |
Bain Capital Life Sciences Investors, LLC | Investment Advisor | 9.2054 | 4886616 | 0 | 2023-03-31 | LOW |
Adage Capital Management, L.P. | Hedge Fund | 6.6875 | 3549975 | 0 | 2023-03-31 | LOW |
Redmile Group, LLC | Investment Advisor/Hedge Fund | 6.5993 | 3503190 | 0 | 2023-03-31 | LOW |
VR Adviser, LLC | Venture Capital | 6.066 | 3220050 | 0 | 2023-03-31 | MED |
Federated Hermes Global Investment Management Corp. | Investment Advisor/Hedge Fund | 5.7603 | 3057800 | 0 | 2023-03-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 4.5459 | 2413117 | -87190 | 2023-03-31 | HIGH |
Eventide Asset Management, LLC | Investment Advisor | 3.5175 | 1867250 | -1759258 | 2023-03-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.9575 | 1569971 | 21100 | 2023-03-31 | LOW |
GMT Capital Corp. | Hedge Fund | 2.6537 | 1408697 | 1408697 | 2023-03-31 | MED |
Millennium Management LLC | Hedge Fund | 2.5702 | 1364343 | 837812 | 2023-03-31 | HIGH |
Cormorant Asset Management, LP | Hedge Fund | 2.3548 | 1250000 | 1250000 | 2023-03-31 | LOW |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 2.3222 | 1232713 | 0 | 2023-03-31 | LOW |
Octagon Capital Advisors LP | Hedge Fund | 2.2417 | 1190000 | 1190000 | 2023-03-31 | MED |
Driehaus Capital Management, LLC | Investment Advisor/Hedge Fund | 2.0552 | 1090986 | -200586 | 2023-03-31 | MED |
Invus Public Equities Advisors, LLC | Investment Advisor | 1.9183 | 1018303 | 1018303 | 2023-03-31 | LOW |
Polar Capital LLP | Investment Advisor/Hedge Fund | 1.8838 | 1000000 | 1000000 | 2023-03-31 | LOW |
Soleus Capital Management, L.P. | Hedge Fund | 1.7244 | 915400 | 915400 | 2023-03-31 | HIGH |
Novartis AG | Corporation | 1.7157 | 910747 | -1196497 | 2021-12-31 | LOW |
Clarus Ventures, LLC | Venture Capital | 1.7147 | 910211 | 0 | 2023-03-31 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Annexon, Inc. Company profile
About Annexon Inc
Annexon, Inc. is a clinical-stage biopharmaceutical company that is developing a pipeline of therapies for patients with classical complement-mediated disorders of the body, brain and eye. The Company’s product candidate, ANX005, is a full-length monoclonal antibody formulated for intravenous administration in autoimmune and neurodegenerative disorders. Its product candidate, ANX007, is an antigen-binding fragment (Fab), formulated for intravitreal administration for the treatment of neurodegenerative ophthalmic disorders. It is also developing ANX009, which is an investigational, subcutaneous formulation of a Fab designed for the treatment of systemic autoimmune diseases. It has completed Phase 1b safety and dose-ranging clinical trials for ANX005 and ANX007 in patients with Guillain-Barre Syndrome (GBS) and glaucoma respectively. It is also conducting clinical trials in multiple serious autoimmune, neurodegenerative and ophthalmic diseases.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Annexon Inc revenues was not reported. Net loss applicable to common stockholders increased 85% to $130.3M. Higher net loss reflects Research and development increase of 91% to $67.1M (expense), Compensation and personnel-related increase from $11.9M to $24.4M (expense), Compensation and personnel-related increase from $5.7M to $13.6M (expense).
Industry: | Biopharmaceuticals |
1400 Sierra Point Parkway
Bldg C Suite 200
BRISBANE
CALIFORNIA 94005
US
Income Statement
- Annual
- Quarterly
News

USD forecast: DXY slides in risk-off market sentiment
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
16:10, 24 May 2023
Oil price forecast: Will WTI and Brent regain momentum in 2023?
Discover the drivers behind Brent and WTI volatility and get insights from analyst predictions.
11:38, 22 May 2023
Weekly Roundup: Tech stocks lead the way
US stocks push higher as risk appetite surges despite the uncertainty
13:39, 19 May 2023
USD/JPY continues to build higher towards 138
USD/JPY advances towards the top of its ascending triangle as the US dollar moves higher
11:50, 17 May 2023
Gold price predictions for next 5 years: Will gold continue rising?
The yellow metal reached near record-highs, yet will it maintain the momentum and for how long?
07:50, 17 May 2023
Gold price forecast: Will gold surpass record highs?
The US debt ceiling concerns and the banking crisis have been favourable for gold, yet is there more upside potential?
12:52, 16 May 2023
Top AI stocks: What companies are leading the AI revolution?
Unravel key AI market leaders and their latest products, key AI industry trends and forecasts.
14:55, 15 May 2023People also watch
Still looking for a broker you can trust?
Join the 530.000+ traders worldwide that chose to trade with Capital.com